Home ALL Evaluating global medical cannabis regulatory regimes: Lessons to be learned for the UK MCWGmedical cannabisreport Evaluating global medical cannabis regulatory regimes: Lessons to be learned for the UK January 31 2020 https://drugscience.org.uk/wp-content/uploads/2020/01/Full-Report.pdf Related ContentProject Twenty21 - January UpdateJanuary 18, 2022Project Twenty21 in 2022: A Message for PatientsJanuary 6, 2022Medical cannabis for severe treatment resistant epilepsy in children: a case series of 10 patientsDecember 15, 2021Project Twenty21 - December UpdateDecember 14, 2021Leading doctors and scientists call for UK paediatricians to recognise the value of medical cannabis for childhood epilepsyDecember 6, 2021Medical Cannabis for Epilepsy - Research Summary and RecommendationsNovember 11, 2021Project Twenty21 - November UpdateNovember 10, 20213 Years Since the UK Legalised Medical Cannabis, and Only 3 NHS PrescriptionsNovember 4, 2021Working in Drug ScienceOctober 15, 2021Project Twenty21 - October UpdateOctober 12, 2021Project Twenty21 - September UpdateSeptember 14, 2021Students “End the Stigma” around medical cannabis this Freshers Week and improve access for young patientsAugust 26, 2021
